This brief document shows the Bureau of Justice Assistance measures for assessment of activities for the years 2021 and 2022, and provides insights into how the Comprehensive Opioid, Stimulant, and Substance Use Program is impacting stakeholders, communities, and individuals throughout the U.S.
In this document, the Bureau of Justice Assistance (BJA) presents its assessment of activities for the years 2021 and 2022, and provides data on several Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) priority areas. The COSSUP funding highlights section summarizes performance data reported by grantees or subgrantees who were active in calendar year (CY) 2021 and 2022. The document provides breakdowns of Naloxone training categories for 2021 and 2022; law enforcement (LE)-led programs; and key COSSUP activities, including diversion and deflection, treatment courts and community supervision, and jail and reentry-based programming. The document also informs of COSSUP’s substance use treatment services, including inpatient, outpatient, partial hospitalization programs 9PHP, mental health treatment, family therapy, and more.
Downloads
Similar Publications
- Implementation of Electronic Health Record Integration and Clinical Decision Support to Improve Emergency Department Prescription Drug Monitoring Program Use
- FY 2024 Solicitation Overview: Visiting Fellows Program
- Offering Recovery Rather Than Punishment: Implementation of a Law Enforcement-led Pre-arrest Diversion-to-treatment Program for Adults with Substance Use Disorders